Scanning mutagenesis studies of the M1 muscarinic acetylcholine receptor

Receptors and Channels

Volumn 9, Issue 4, 2003, Pages 215-228

  Hulme, E C ^a   Lu, Z L ^b   Bee, M S ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Acetylcholine; G Protein; GPCR; Muscarinic; Rhodopsin

Indexed keywords

ACETYLCHOLINE; AMINO ACID; AROMATIC COMPOUND; LIGAND; MEMBRANE PROTEIN; METHYLSCOPOLAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M1 RECEPTOR AGONIST; MUSCARINIC M1 RECEPTOR ANTAGONIST; RHODOPSIN;

BINDING AFFINITY; BINDING SITE; CHEMICAL PARAMETERS; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENERGY; GENE MAPPING; GENETIC CONSERVATION; GENETIC SCREENING; HYDROGEN BOND; MOLECULAR INTERACTION; MOLECULAR MODEL; MUTAGENESIS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN STABILITY; RECEPTOR AFFINITY; REVIEW; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

ACETYLCHOLINE; AMINO ACIDS; HUMANS; MUTATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, MUSCARINIC M1;

BOVINAE;

EID: 0041411237     PISSN: 10606823     EISSN: None     Source Type: Journal    
DOI: 10.1080/10606820308261     Document Type: Review

References (64)

1. Alewjinse, A. E., Timmerman, H., Jacobs, H., Jacobs, E. H., Smit, M. J., Roovers, E., Cotecchia, S., and Leurs, R. 2000. Mol. Pharmacol. 57:890-898.
2. Allman, K., Page, K. M., Curtis, C. A. M., and Hulme, E. C. 2000. Mol. Pharmacol. 58:175-184.
3. Axelsen, P. H., Harel, M., Silman, I., and Sussman, J. L. 1994. Protein Sci. 3:188-197.
4. Baldwin, J. M., Schertler, G. F. X., and Unger, V. M. 1997. J. Mol. Biol. 272: 144-164.
5. Ballesteros, J. A., Jensen, A. D., Liapakis, G., Rasmussen, S. G. F., Shi, L., Gether, U., and Javitch, J. A. 2001. J. Biol. Chem. 276:29171-29177.
6. Ballesteros, J. A., Shi, L., and Javitch, J. A. 2001. Mol. Pharmacol. 60:1-19.
7. Ballesteros, J. A., and Weinstein, H. 1995. Methods Neurosci. 25:366-428.
8. Barlow, R. B. 1964. Introduction to Chemical Pharmacology, 2nd ed. Methuen & Co. Ltd., London.
9. Birdsall, N. J., Lazareno, S., Popham, A., and Saldanha, J. 2001. Life Sci. J.I.D.-0375521. 68:2517-2524.
10. Brejc, K., Van Dijk, W. J., Klaassen, R. V., Schuurmans, M., Van der Oost, J., Smit, A. B., and Sixma, T. K. 2001. Nature 411:269-276.
11. Caulfield, M. P., and Birdsall, N. J. 1998. Pharmacol. Rev. J.I.D.-0421737. 50:279-290.
12. Chen, S., Lin, F., Xu, M., and Graham, R. M. 2002. Biochemistry J.I.D.-0370623 41:588-596.
13. Elling, C. E., Raffetseder, U., Nielsen, S. M., and Schwartz, T. W. 2000. Biochemistry 39:667-675.
14. Flanagan, C. A., Zhou, W., Chi, L., Yuen, T., Rodic, V., Robertson, D., Johnson, M., Millar, R. P., Weinstein, H., Mitchell, R., and Sealfon, S. C. 1999. J. Biol. Chem. 274:28880-28886.
15. Ford, D. J., Essex, A., Spalding, T. A., Burstein, E. S., and Ellis, J. 2002. J. Pharmacol. Exp. Ther. J.I.D.-0376362 300:810-817.
16. Furukawa, H., Hamada, T., Hagashi, M. K., Haga, T., Muto, Y., Hirota, H., Yokoyama, S., Nagasawa, K., and Ishiguro, M. 2002. Mol. Pharmacol. 62:778-787.
17. Gerber, B. O., Meng, E. C., Dotsch, V., Baranski, T. J., and Bourne, H. R. 2001. J. Biol. Chem. 276:3394-3400.
18. Gether, U. 2000. Endocrine Reviews 21:90-113.
19. Ghanouni, P., Gryczynski, Z., Steenhuis, J. J., Lee, T. W., Farrens, D. L., Lakowicz, J. R., and Kobilka, B. K. 2001. J. Biol. Chem. 276:24433-24436.
20. Hamilton, S. E., and Nathanson, N. M. 2001. J. Biol. Chem. 276:15850-15853.
21. Heitz, F., Holzwarth, J. A., Gies, J.-P., Pruss, R. M., Trumpp-Kallmeyer, S., Hibert, M., and Guenet, C. 1999. Eur. J. Pharmacol. 380:183-195.
22. Hibert, M., Trumpp-Kallmeyer, S., Bruinvels, A., and Hoflack, J. 1991. Mol. Pharmacol. 40:8-15.
23. Högger, P., Shockley, M. S., Lameh, J., and Sadee, W. 1995. J. Biol. Chem. 270:7405-7410.
24. Holst, B., Zoffmann, S., Elling, C. E., Hjorth, S. A., and Schwartz, T. W. 1998. Mol. Pharmacol. 53:166-175.
25. Hulme, E. C., Birdsall, N. J., and Buckley, N. J. 1990. Ann. Rev. Pharmcol. Toxicol. 30:633-673.
26. Hulme, E. C., and Lu, Z.-L. 1998. J. Physiol. (Paris) 92:269-274.
27. Hulme, E. C., Lu, Z.-L., Ward, S. D. C., Allman, K., and Curtis, C. A. M. 1999. Eur. J. Pharmacol. 375:247-260.
28. International Human Genome Sequencing Consortium. 2001. Nature 409:860-922.
29. Jakubik, J., El-Fakahany, E. E., and Tucek, S. 2000. J. Biol. Chem. 275:18836-18844.
30. Javitch, J. A., Fu, D., Chen, J., and Karlin, A. 1995. Neuron 14:825-831.
31. Jones, P. G., Curtis, C. A., and Hulme, E. C. 1995. Eur. J. Pharmacol. 288:251-257.
32. Konvicka, K., Guarnieri, F., Ballesteros, J., and Weinstein, H. 1998. Biophys. J. 75:601-611.
33. Lapinsh, M., Gutcaits, A., Prusis, P., Post, C., Lundstedt, T., and Wikberg, J. E. 2002. Protein Sci. J.I.D.-9211750 11:795-805.
34. Lu, Z.-L., Curtis, C. A. M., Jones, P. G., Pavia, J., and Hulme, E. C. 1997. Mol. Pharmacol. 51:234-241.
35. Lu, Z.-L., and Hulme, E. C. 1999. J. Biol. Chem. 274:7309-7315.
36. Lu, Z.-L., and Hulme, E. C. 2000. J. Biol. Chem. 275:5682-5686.
37. Lu, Z.-L., Saldanha, J., and Hulme, E.C. 2001. J. Biol. Chem. 276:34098-34104.
38. Lu, Z. L., Saldanha, J. W., and Hulme, E. C. 2002. Trends Pharmacol. Sci. J.I.D.-7906158 23:140-146.
39. Ma, J. C., and Dougherty, D. A. 1997. Chem. Rev. 97:1303-1324.
40. Matsui, H., Lazareno, S., and Birdsall, N. J. M. 1995. Mol. Pharmacol. 47:88-98.
41. Meng, E. C., and Bourne, H. R. 2001. Trends Pharmacol. Sci. 22:587-593.
42. Nathanson, N. M. 2000. Proc. Natl. Acad. Sci. U.S.A. 97:6245-6247.
43. Okada, T., Fujiyoshi, Y., Silow, M., Navarro, J., Landau, E. M., and Shichida, Y. 2002. Proc. Natl. Acad. Sci. U.S.A. 99:5982-5987.
44. Ovchinnikov, Y. A. 1982. FEBS Lett. 148:179-190.
45. Page, K. M., Curtis, C. A. M., Jones, P. G., and Hulme, E. C. 1995. Eur. J. Pharmacol. 289:429-437.
46. Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Le Trong, I., Teller, D. C., Okada, T., Stenkamp, R. E., Yamamoto, M., and Miyano, M. 2000. Science 289:739-745.
47. Rosenblum, K., Futter, M., Jones, M., Hulme, E. C., and Bliss, T. V. 2000. J. Neurosci. J.I.D.-8102140 20:977-985.
48. Samama, P., Cotecchia, S., Costa, T., and Lefkowitz, R. J. 1993. J. Biol. Chem. 268:4625-4636.
49. Scheer, A., Fanelli, F., Costa, T., De Benedetti, P. G., and Cotecchia, S. 1997. Proc. Natl. Acad. Sci. U.S.A. 94:808-813.
50. Schulman, J. M., Sabio, M. L., and Disch, R. L. 1983. J. Med. Chem. 26:817-823.
51. Shapiro, D. A., Kristiansen, K., Weiner, D. M., Kroeze, W. K., and Roth, B. L. 2002. J. Biol. Chem. J.I.D.-2985121R 277:11441-11449.
52. Shi, L., and Javitch, J. A. 2002. Annu. Rev. Pharmacol. Toxicol. J.I.D.-7607088 42:437-467.
53. Spalding, T. A., Burstein, E. S., Henderson, S. C., Ducote, K. R., and Brann, M. R. 1998. J. Biol. Chem. 273:21563-21568.
54. Tao, Y.-X., Abell, A. N., Liu, X., Nakamura, K., and Segaloff, D. L. 2000. Mol. Endocrinol. 14:1272-1282.
55. Teller, D. C., Okada, T., Behnke, C. A., Palczewski, K., and Stenkamp, R. E. 2001. Biochemistry 40:7761-7772.
56. Unger, V. M., Hargrave, P. A., Baldwin, J. M., and Schertler, G. F. 1997. Nature 389:203-206.
57. Venter, J. C. et al. 2001. Science 291:1304-1350.
58. Waelbroeck, M. 2001a. Mol. Pharmacol. 59:875-885.
59. Waelbroeck, M. 2001b. Mol. Pharmacol. 59:886-893.
60. Ward, S. D. C., Curtis, C. A. M., and Hulme, E. C. 1999. Mol. Pharmacol. 56:1031-1041.
61. Ward, S. D. C., Hamdan, F. F., Bloodworth, L. M., and Wess, J. 2002. J. Biol. Chem. 277:2247-2257.
62. Wells, J. A. 1991. Meth. Enzymol. 202:390-411.
63. Wess, J., Nanavati, S., Vogel, Z., and Maggio, R. 1993. EMBO J. 12:331-338.
64. Zeng, F.-Y., Soldner, A., Schoneberg, T., and Wess, J. 1999. J. Neurochem. 72:2404-2414.